Triamcinolone Acetonide
- Product NDC
- 46708-091
- Requested package NDC
- 46708-091-10
- 11-digit product format
- 467080091
- Labeler code
- 46708
- Product ID
- 46708-091_c0b487dd-a47b-42fd-a855-5d237c5651a9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamcinolone Acetonide
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRA-ARTICULAR; INTRAMUSCULAR
- Labeler
- Alembic Pharmaceuticals Limited
- Application
- ANDA218601
- Marketing category
- ANDA
- Marketing start
- 2025-10-17
- Substance
- TRIAMCINOLONE ACETONIDE
- Active strength
- 400 mg/10mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218601-001 | TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | 40MG/ML | INJECTABLE / INJECTION | AB | 2025-10-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218601-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218601-001 | TRIAMCINOLONE ACETONIDE | 40MG/ML | INJECTABLE / INJECTION | AB | 2025-10-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218601-001 | TRIAMCINOLONE ACETONIDE | 40MG/ML | INJECTABLE / INJECTION | AB | 2025-10-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218601-001 | TRIAMCINOLONE ACETONIDE | 40MG/ML | INJECTABLE / INJECTION | AB | 2025-10-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218601-001 | TRIAMCINOLONE ACETONIDE | 40MG/ML | INJECTABLE / INJECTION | AB | 2025-10-17 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218601-001 | TRIAMCINOLONE ACETONIDE | 40MG/ML | INJECTABLE / INJECTION | AB | 2025-10-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218601-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218601-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218601-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218601-001 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218601-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Triamcinolone Acetonide
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TRIAMCINOLONE ACETONIDE | 400 mg/10mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F446C597KA | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c0b487dd-a47b-42fd-a855-5d237c5651a9 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d4d7da1a-7fd4-628e-cdae-89e749b1c534 | Product name | 7 | 20260127 |
| 75f7e47b-8736-a182-fc44-22aca8d79689 | Product name | 2 | 20251211 |
| 62986c8d-91f1-b1ba-b5a3-8b54b75bb8c2 | Product name | 6 | 20250516 |
| e42f429b-c4e5-0402-e1c5-730154df4060 | Product name | 4 | 20240205 |
| 38d4de13-64b3-4057-b91c-4b5126962341 | Product name | 1 | 20220516 |
| 089e0644-1ea8-8654-4113-39f960dd57d5 | Product name | 3 | 20210115 |
| 1629e00f-54fb-4a43-8306-b58442b23902 | Product name | 9 | 20200430 |
| 5331c9c8-f64b-11e6-ccf1-071c477fcb0b | Product name | 7 | 20190612 |
| 9f64e0dc-109c-9660-8e0e-91ec987b3817 | Product name | 6 | 20171204 |
| dfa879a3-32de-49f0-a7ba-9b9c3e13002f | Product name | 1 | 20171204 |
| 8de20f81-8411-4cf1-a8b2-03404ee56d01 | Product name | 3 | 20171109 |
| a5f1a68c-0352-4f34-46a3-9b4eed239ed8 | Product name | 2 | 20160819 |
| 355b2224-0895-7135-83f5-d099a6a82a0a | Product name | 1 | 20140508 |
| 55be6b50-8cc0-f0f1-74a1-3416a91193aa | Product name | 1 | 20140508 |
| 7a0092d1-1e8c-0d78-4f8d-d95fa15cc3cf | Product name | 1 | 20140508 |
| 89b93c13-4be8-69f3-b33b-63e64feffb9b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 46708-091-10 | Triamcinolone Acetonide | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SUSPENSION | 10 | 1 | |
| 46708-091-10 | Triamcinolone Acetonide | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Sagent Pharmaceuticals | 7dbee70b-bd11-4430-b626-97fbb8f01b49 | 2026-08-14 | Warnings, Adverse reactions | 218601 ANDA218601 |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Alembic Pharmaceuticals Inc. | 05c2a9cf-a018-48c0-9c73-2d59d52211d2 | 2025-11-03 | Warnings, Adverse reactions | 218601 ANDA218601 |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Alembic Pharmaceuticals Limited | c0b487dd-a47b-42fd-a855-5d237c5651a9 | 2025-11-03 | Warnings, Adverse reactions | 218601 ANDA218601 46708-091-10 46708-091 46708009110 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1792144 | triamcinolone acetonide 40 MG in 1 ML Injection | PSN | c0b487dd-a47b-42fd-a855-5d237c5651a9 | 1 |
| 1085754 | triamcinolone acetonide 40 MG/ML Injectable Suspension | PSN | c0b487dd-a47b-42fd-a855-5d237c5651a9 | 1 |
| 1792144 | 1 ML triamcinolone acetonide 40 MG/ML Injection | SCD | c0b487dd-a47b-42fd-a855-5d237c5651a9 | 1 |
| 1085754 | triamcinolone acetonide 40 MG/ML Injectable Suspension | SCD | c0b487dd-a47b-42fd-a855-5d237c5651a9 | 1 |
| 1792144 | triamcinolone acetonide 40 MG per 1 ML Injection | SY | c0b487dd-a47b-42fd-a855-5d237c5651a9 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 46708-091-10 | 46708009110 | 1 VIAL, MULTI-DOSE in 1 CARTON (46708-091-10) / 10 mL in 1 VIAL, MULTI-DOSE | 2025-10-17 | No | No | Current |